As expected, sh‐SIRT3 + oe‐NC treatment strikingly promoted tumor volume and weight relative to sh‐NC + oe‐NC, which was reversed by CDT1 overexpression (Figure 6A). This evidence concerns the gene SIRT3 and neoplasm.